Carlyle Group Inc.
$34.77B- Market cap
- $16.74B
- Debt
- +$20.00B
- Cash
- −$1.97B
Capital structure 46% equity / 54% debt · EV / Revenue 7.27x · EV / EBITDA 25.38x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2024 ·
Decision snapshot: CG stock price vs AZPN: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at AZPN's multiple
Needs AZPN P/E.
Implied fair value · at CG's multiple
Needs EPS (TTM) is negative, CG P/E.
Metric by metric
Price unavailable
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: CG FY 2025 (ended Dec 31, 2025) · AZPN FY 2024 (ended Jun 30, 2024). Fiscal years are not aligned.
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 46% equity / 54% debt · EV / Revenue 7.27x · EV / EBITDA 25.38x
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Carlyle Group Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
ASPEN TECHNOLOGY, INC. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
2.83x
-0.17x
Net debt / EBITDA
Leverage against operating earnings
13.16x
-5.17x
Cash and equivalents
Liquid reserves on the balance sheet
$1.97B
$236.97M
Total debt
Interest-bearing obligations outstanding
$20.00B
-$2.20B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.